{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:07:33Z","timestamp":1794571653306,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001935"],"award-info":[{"award-number":["82001935"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902334"],"award-info":[{"award-number":["81902334"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["6590009646"],"award-info":[{"award-number":["6590009646"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Interventional brachytherapy, such as iodine-125(<jats:sup>125<\/jats:sup>I), has improved the survival of obstructive late-stage esophageal cancer patients. However, most patients experience radioresistance after <jats:sup>125<\/jats:sup>I brachytherapy. It is key to decipher the underlying mechanism of <jats:sup>125<\/jats:sup>I radioresistance. In this study, we identified an endoplasmic reticulum-associated protein, P4HA2, which is upregulated and mediates resistance to <jats:sup>125<\/jats:sup>I treatment. Mechanistically, P4HA2 enhances mitochondrial autophagy (mitophagy) via the PINK1\/parkin pathway by binding to ATAD3A. Clinically, high expression of P4HA2 correlates with shorter overall survival and predicts poor prognosis with <jats:sup>125<\/jats:sup>I brachytherapy. Moreover, the expression of P4HA2 is epigenetically increased by IGF2BP2 in an m<jats:sup>6<\/jats:sup>A-dependent manner. Notably, targeting P4HA2 with siRNA-based biocompatible nanomedicines significantly sensitizes ESCC to <jats:sup>125<\/jats:sup>I brachytherapy. Collectively, our results show the molecular mechanism of mitophagy-mediated <jats:sup>125<\/jats:sup>I radioresistance, which provides a potential therapeutic target and combinatorial strategy.<\/jats:p>","DOI":"10.1038\/s41419-025-07864-x","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:33:33Z","timestamp":1759732413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["P4HA2 interacted with ATAD3A to modulate PINK1\/parkin-dependent mitophagy and 125I brachytherapy sensitization in esophageal carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Xijuan","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9982-8622","authenticated-orcid":false,"given":"Xing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songzhe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaxing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaizhi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongkai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binda","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4620-2930","authenticated-orcid":false,"given":"Jinhe","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2315-7639","authenticated-orcid":false,"given":"Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"7864_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"7864_CR2","doi-asserted-by":"publisher","first-page":"e943","DOI":"10.1016\/S2468-2667(23)00211-6","volume":"8","author":"J Qi","year":"2023","unstructured":"Qi J, Li M, Wang L, Hu Y, Liu W, Long Z, et al. National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data. Lancet Public Health. 2023;8:e943\u2013e955.","journal-title":"Lancet Public Health"},{"key":"7864_CR3","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/S1470-2045(14)70131-7","volume":"15","author":"H-D Zhu","year":"2014","unstructured":"Zhu H-D, Guo J-H, Mao A-W, Lv W-F, Ji J-S, Wang W-H, et al. Conventional stents versus stents loaded with (125)iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial. Lancet Oncol. 2014;15:612\u20139.","journal-title":"Lancet Oncol"},{"key":"7864_CR4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1148\/radiol.2472070999","volume":"247","author":"J-H Guo","year":"2008","unstructured":"Guo J-H, Teng G-J, Zhu G-Y, He S-C, Fang W, Deng G, et al. Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer. Radiology. 2008;247:574\u201381.","journal-title":"Radiology"},{"key":"7864_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.717180","volume":"11","author":"S Wei","year":"2021","unstructured":"Wei S, Li C, Li M, Xiong Y, Jiang Y, Sun H, et al. Radioactive iodine-125 in tumor therapy: advances and future directions. Front Oncol. 2021;11:717180.","journal-title":"Front Oncol"},{"key":"7864_CR6","first-page":"5969","volume":"16","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zhu Y, Dong M, Yang J, Weng W, Teng L. Iodine-125 interstitial brachytherapy reduces tumor growth via Warburg effect inhibition in non-small cell lung cancer A549 xenografts. Oncol Lett. 2018;16:5969\u201377.","journal-title":"Oncol Lett"},{"key":"7864_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121801","volume":"289","author":"X Yao","year":"2022","unstructured":"Yao X, Lu S, Feng C, Suo R, Li H, Zhang Y, et al. Tumor oxygenation nanoliposome synergistic hypoxia-inducible-factor-1 inhibitor enhanced Iodine-125 seed brachytherapy for esophageal cancer. Biomaterials. 2022;289:121801.","journal-title":"Biomaterials"},{"key":"7864_CR8","first-page":"2028","volume":"43","author":"C Wang","year":"2020","unstructured":"Wang C, Li T-K, Zeng C-H, Fan R, Wang Y, Zhu G-Y, et al. Iodine\u2011125 seed radiation induces ROS\u2011mediated apoptosis, autophagy and paraptosis in human esophageal squamous cell carcinoma cells. Oncol Rep. 2020;43:2028\u201344.","journal-title":"Oncol Rep"},{"key":"7864_CR9","doi-asserted-by":"publisher","first-page":"620","DOI":"10.4149\/neo_2022_211102N1556","volume":"69","author":"L Zou","year":"2022","unstructured":"Zou L, Chang W, Bai J-H, Shi W-H, Jin Y, Wang J-F, et al. Iodine-125 induced cholangiocarcinoma cell death is enhanced by inhibition of endoplasmic reticulum stress-mediated protective autophagy. Neoplasma. 2022;69:620\u20139.","journal-title":"Neoplasma"},{"key":"7864_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1667\/RADE-20-00057.1","volume":"194","author":"C Wang","year":"2020","unstructured":"Wang C, Li T-K, Zeng C-H, Yang J, Wang Y, Lu J, et al. Inhibition of endoplasmic reticulum stress-mediated autophagy enhances the anticancer effect of iodine-125 seed radiation on esophageal squamous cell carcinoma. Radiat Res. 2020;194:236\u201345.","journal-title":"Radiat Res"},{"key":"7864_CR11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41419-019-1918-1","volume":"10","author":"D Li","year":"2019","unstructured":"Li D, Wang W-J, Wang Y-Z, Wang Y-B, Li Y-L. Lobaplatin promotes 125I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2\u03b1-ATF4-CHOP pathway. Cell Death Dis. 2019;10:744.","journal-title":"Cell Death Dis"},{"key":"7864_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.semcancer.2019.07.015","volume":"66","author":"DP Panigrahi","year":"2020","unstructured":"Panigrahi DP, Praharaj PP, Bhol CS, Mahapatra KK, Patra S, Behera BP, et al. The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics. Semin Cancer Biol. 2020;66:45\u201358.","journal-title":"Semin Cancer Biol"},{"key":"7864_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","volume":"8","author":"W Chen","year":"2023","unstructured":"Chen W, Zhao H, Li Y. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduct Target Ther. 2023;8:333.","journal-title":"Signal Transduct Target Ther"},{"key":"7864_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41420-023-01573-0","volume":"9","author":"Y Ren","year":"2023","unstructured":"Ren Y, Yang P, Li C, Wang W-A, Zhang T, Li J, et al. Ionizing radiation triggers mitophagy to enhance DNA damage in cancer cells. Cell Death Discov. 2023;9:267.","journal-title":"Cell Death Discov"},{"key":"7864_CR15","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1111\/febs.16769","volume":"290","author":"Y Wei","year":"2023","unstructured":"Wei Y, Xiao G, Xu H, Sun X, Shi Y, Wang F, et al. Radiation resistance of cancer cells caused by mitochondrial dysfunction depends on SIRT3-mediated mitophagy. FEBS J. 2023;290:3629\u201345.","journal-title":"FEBS J"},{"key":"7864_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2021.07.019","volume":"518","author":"Q Chen","year":"2021","unstructured":"Chen Q, Zheng W, Zhu L, Liu H, Song Y, Hu S, et al. LACTB2 renders radioresistance by activating PINK1\/Parkin-dependent mitophagy in nasopharyngeal carcinoma. Cancer Lett. 2021;518:127\u201339.","journal-title":"Cancer Lett"},{"key":"7864_CR17","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/s41416-018-0337-x","volume":"119","author":"MS Toss","year":"2018","unstructured":"Toss MS, Miligy IM, Gorringe KL, AlKawaz A, Khout H, Ellis IO, et al. Prolyl-4-hydroxylase \u0391 subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS). Br J cancer. 2018;119:1518\u201326.","journal-title":"Br J cancer"},{"key":"7864_CR18","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201247R","volume":"37","author":"X Li","year":"2023","unstructured":"Li X, Li Y, Liu B, Chen L, Lyu F, Zhang P, et al. P4HA2-mediated HIF-1\u03b1 stabilization promotes erdafitinib-resistance in FGFR3-alteration bladder cancer. FASEB J. 2023;37:e22840.","journal-title":"FASEB J"},{"key":"7864_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-1","volume":"14","author":"G Xiong","year":"2014","unstructured":"Xiong G, Deng L, Zhu J, Rychahou PG, Xu R. Prolyl-4-hydroxylase \u03b1 subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition. BMC Cancer. 2014;14:1.","journal-title":"BMC Cancer"},{"key":"7864_CR20","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1182\/blood-2017-07-794875","volume":"131","author":"W Jiang","year":"2018","unstructured":"Jiang W, Zhou X, Li Z, Liu K, Wang W, Tan R, et al. Prolyl 4-hydroxylase 2 promotes B-cell lymphoma progression via hydroxylation of Carabin. Blood. 2018;131:1325\u201336.","journal-title":"Blood"},{"key":"7864_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ebiom.2019.06.048","volume":"45","author":"T Wang","year":"2019","unstructured":"Wang T, Fu X, Jin T, Zhang L, Liu B, Wu Y, et al. Aspirin targets P4HA2 through inhibiting NF-\u03baB and LMCD1-AS1\/let-7g to inhibit tumour growth and collagen deposition in hepatocellular carcinoma. EBioMedicine. 2019;45:168\u201380.","journal-title":"EBioMedicine"},{"key":"7864_CR22","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.7150\/jca.38401","volume":"11","author":"Y Cao","year":"2020","unstructured":"Cao Y, Han Q, Li J, Jia Y, Zhang R, Shi H. P4HA2 contributes to cervical cancer progression via inducing epithelial-mesenchymal transition. J Cancer. 2020;11:2788\u201399.","journal-title":"J Cancer"},{"key":"7864_CR23","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/mp.16760","volume":"51","author":"Z Xiao","year":"2023","unstructured":"Xiao Z, Xiong T, Geng L, Zhou F, Liu B, Sun H, et al. Automatic planning for head and neck seed implant brachytherapy based on deep convolutional neural network dose engine. Med Phys. 2023;51:1460\u201373.","journal-title":"Med Phys"},{"key":"7864_CR24","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1038\/s41388-021-01692-x","volume":"40","author":"C Cheng","year":"2021","unstructured":"Cheng C, Pei X, Li S-W, Yang J, Li C, Tang J, et al. CRISPR\/Cas9 library screening uncovered methylated PKP2 as a critical driver of lung cancer radioresistance by stabilizing \u03b2-catenin. Oncogene. 2021;40:2842\u201357.","journal-title":"Oncogene"},{"key":"7864_CR25","doi-asserted-by":"publisher","first-page":"e2110428119","DOI":"10.1073\/pnas.2110428119","volume":"119","author":"X Yang","year":"2022","unstructured":"Yang X, Wen Y, Liu S, Duan L, Liu T, Tong Z. et al. LCDR regulates the integrity of lysosomal membrane by hnRNP K-stabilized LAPTM5 transcript and promotes cell survival. Proc Natl Acad Sci USA. 2022;119:e2110428119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7864_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2017.09.005","volume":"113","author":"RT Cowling","year":"2017","unstructured":"Cowling RT, Park JI, Sotimehin AE, Greenberg BH. Ascorbate starvation alters endoplasmic reticulum-resident enzymes in cardiac fibroblasts, priming them for increased procollagen secretion. J Mol Cell Cardiol. 2017;113:1\u20138.","journal-title":"J Mol Cell Cardiol"},{"key":"7864_CR27","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gkab418","volume":"49","author":"C Li","year":"2021","unstructured":"Li C, Tang Z, Zhang W, Ye Z, Liu F. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 2021;49:W242\u2013W246.","journal-title":"Nucleic Acids Res"},{"key":"7864_CR28","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/cjp2.281","volume":"8","author":"R Li","year":"2022","unstructured":"Li R, Huang X, Yang W, Wang J, Liang Y, Zhang T, et al. Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma. J Pathol Clin Res. 2022;8:422\u201335.","journal-title":"J Pathol Clin Res"},{"key":"7864_CR29","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1038\/s41388-021-02000-3","volume":"40","author":"M Zhu","year":"2021","unstructured":"Zhu M, Peng R, Liang X, Lan Z, Tang M, Hou P, et al. P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasis. Oncogene. 2021;40:6049\u201356.","journal-title":"Oncogene"},{"key":"7864_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01801-2","volume":"22","author":"Y Wu","year":"2023","unstructured":"Wu Y, Song Y, Wang R, Wang T. Molecular mechanisms of tumor resistance to radiotherapy. Mol Cancer. 2023;22:96.","journal-title":"Mol Cancer"},{"key":"7864_CR31","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrm2239","volume":"8","author":"MC Maiuri","year":"2007","unstructured":"Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007;8:741\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7864_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41422-022-00766-z","volume":"33","author":"X-Q Xie","year":"2023","unstructured":"Xie X-Q, Yang Y, Wang Q, Liu H-F, Fang X-Y, Li C-L, et al. Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria. Cell Res. 2023;33:215\u201328.","journal-title":"Cell Res"},{"key":"7864_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13046-020-01768-8","volume":"39","author":"H Wu","year":"2020","unstructured":"Wu H, Wang T, Liu Y, Li X, Xu S, Wu C, et al. Mitophagy promotes sorafenib resistance through hypoxia-inducible ATAD3A dependent Axis. J Exp Clin Cancer Res. 2020;39:274.","journal-title":"J Exp Clin Cancer Res"},{"key":"7864_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41590-017-0002-1","volume":"19","author":"G Jin","year":"2018","unstructured":"Jin G, Xu C, Zhang X, Long J, Rezaeian AH, Liu C, et al. Atad3a suppresses Pink1-dependent mitophagy to maintain homeostasis of hematopoietic progenitor cells. Nat Immunol. 2018;19:29\u201340.","journal-title":"Nat Immunol"},{"key":"7864_CR35","doi-asserted-by":"publisher","first-page":"6481","DOI":"10.1002\/jcp.30323","volume":"236","author":"KC Huang","year":"2021","unstructured":"Huang KC, Chiang SF, Yang PC, Ke TW, Chen TW, Lin CY, et al. ATAD3A stabilizes GRP78 to suppress ER stress for acquired chemoresistance in colorectal cancer. J Cell Physiol. 2021;236:6481\u201395.","journal-title":"J Cell Physiol"},{"key":"7864_CR36","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41419-022-05345-z","volume":"13","author":"Q Li","year":"2022","unstructured":"Li Q, Chu Y, Li S, Yu L, Deng H, Liao C, et al. The oncoprotein MUC1 facilitates breast cancer progression by promoting Pink1-dependent mitophagy via ATAD3A destabilization. Cell Death Dis. 2022;13:899.","journal-title":"Cell Death Dis"},{"key":"7864_CR37","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1080\/15548627.2021.1997052","volume":"18","author":"M Di Rienzo","year":"2022","unstructured":"Di Rienzo M, Romagnoli A, Ciccosanti F, Refolo G, Consalvi V, Arena G, et al. AMBRA1 regulates mitophagy by interacting with ATAD3A and promoting PINK1 stability. Autophagy. 2022;18:1752\u201362.","journal-title":"Autophagy"},{"key":"7864_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/15548627.2021.1888244","volume":"18","author":"P Tere\u0161ak","year":"2022","unstructured":"Tere\u0161ak P, Lapao A, Subic N, Boya P, Elazar Z, Simonsen A. Regulation of PRKN-independent mitophagy. Autophagy. 2022;18:24\u201339.","journal-title":"Autophagy"},{"key":"7864_CR39","doi-asserted-by":"publisher","first-page":"5182","DOI":"10.1038\/s41388-021-01919-x","volume":"40","author":"S Kaluz","year":"2021","unstructured":"Kaluz S, Zhang Q, Kuranaga Y, Yang H, Osuka S, Bhattacharya D, et al. Targeting HIF-activated collagen prolyl 4-hydroxylase expression disrupts collagen deposition and blocks primary and metastatic uveal melanoma growth. Oncogene. 2021;40:5182\u201391.","journal-title":"Oncogene"},{"key":"7864_CR40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2302291120","volume":"120","author":"Y Pan","year":"2023","unstructured":"Pan Y, Gu Y, Liu T, Zhang Q, Yang F, Duan L, et al. Epitranscriptic regulation of HRAS by N6-methyladenosine drives tumor progression. Proc Natl Acad Sci USA. 2023;120:e2302291120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7864_CR41","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/0008-5472.CAN-20-1619","volume":"81","author":"Y Gu","year":"2021","unstructured":"Gu Y, Niu S, Wang Y, Duan L, Pan Y, Tong Z, et al. Mediated regulation of mA-modified by mA reader IGF2BP3 drives ccRCC progression. Cancer Res. 2021;81:923\u201334.","journal-title":"Cancer Res"},{"key":"7864_CR42","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.ymthe.2021.01.019","volume":"29","author":"J He","year":"2021","unstructured":"He J, Zhou M, Yin J, Wan J, Chu J, Jia J, et al. METTL3 restrains papillary thyroid cancer progression via m6A\/c-Rel\/IL-8-mediated neutrophil infiltration. Mol Ther. 2021;29:1821\u201337.","journal-title":"Mol Ther"},{"key":"7864_CR43","doi-asserted-by":"publisher","first-page":"D1405","DOI":"10.1093\/nar\/gkaa811","volume":"49","author":"X Luo","year":"2021","unstructured":"Luo X, Li H, Liang J, Zhao Q, Xie Y, Ren J, et al. RMVar: an updated database of functional variants involved in RNA modifications. Nucleic Acids Res. 2021;49:D1405\u2013D1412.","journal-title":"Nucleic Acids Res"},{"key":"7864_CR44","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nature18298","volume":"534","author":"X Wang","year":"2016","unstructured":"Wang X, Feng J, Xue Y, Guan Z, Zhang D, Liu Z, et al. Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature. 2016;534:575\u20138.","journal-title":"Nature"},{"key":"7864_CR45","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285\u201395.","journal-title":"Nat Cell Biol"},{"key":"7864_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16306-5","volume":"11","author":"Z Li","year":"2020","unstructured":"Li Z, Peng Y, Li J, Chen Z, Chen F, Tu J, et al. N6-methyladenosine regulates glycolysis of cancer cells through PDK4. Nat Commun. 2020;11:2578.","journal-title":"Nat Commun"},{"key":"7864_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/HEP.0000000000000317","volume":"78","author":"J Zhang","year":"2023","unstructured":"Zhang J, Lyu Z, Li B, You Z, Cui N, Li Y, et al. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases. Hepatology. 2023;78:10\u201325.","journal-title":"Hepatology"},{"key":"7864_CR48","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100532","volume":"38","author":"D Pankova","year":"2019","unstructured":"Pankova D, Jiang Y, Chatzifrangkeskou M, Vendrell I, Buzzelli J, Ryan A, et al. RASSF1A controls tissue stiffness and cancer stem-like cells in lung adenocarcinoma. EMBO J. 2019;38:e100532.","journal-title":"EMBO J"},{"key":"7864_CR49","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1158\/0008-5472.CAN-18-2070","volume":"79","author":"C D\u2019Aniello","year":"2019","unstructured":"D\u2019Aniello C, Cermola F, Palamidessi A, Wanderlingh LG, Gagliardi M, Migliaccio A, et al. Collagen prolyl hydroxylation-dependent metabolic perturbation governs epigenetic remodeling and mesenchymal transition in pluripotent and cancer cells. Cancer Res. 2019;79:3235\u201350.","journal-title":"Cancer Res"},{"key":"7864_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2020.104487","volume":"116","author":"T Zhang","year":"2020","unstructured":"Zhang T, Piao H-Y, Guo S, Zhao Y, Wang Y, Zheng Z-C, et al. LncRNA PCGEM1 enhances metastasis and gastric cancer invasion through targeting of miR-129-5p to regulate P4HA2 expression. Exp Mol Pathol. 2020;116:104487.","journal-title":"Exp Mol Pathol"},{"key":"7864_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110139","volume":"37","author":"T Arguello","year":"2021","unstructured":"Arguello T, Peralta S, Antonicka H, Gaidosh G, Diaz F, Tu YT, et al. ATAD3A has a scaffolding role regulating mitochondria inner membrane structure and protein assembly. Cell Rep. 2021;37:110139.","journal-title":"Cell Rep"},{"key":"7864_CR52","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1080\/15548627.2023.2182482","volume":"19","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhang H, Liu Y, Zhang S, Su P, Wang L, et al. Hypoxia-induced GPCPD1 depalmitoylation triggers mitophagy via regulating PRKN-mediated ubiquitination of VDAC1. Autophagy. 2023;19:2443\u201363.","journal-title":"Autophagy"},{"key":"7864_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9460462","volume":"2016","author":"L Hu","year":"2016","unstructured":"Hu L, Wang H, Huang L, Zhao Y, Wang J. The protective roles of ROS-mediated mitophagy on 125I seeds radiation induced cell death in HCT116 cells. Oxid Med Cell Longev. 2016;2016:9460462.","journal-title":"Oxid Med Cell Longev"},{"key":"7864_CR54","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.","journal-title":"Signal Transduct Target Ther"},{"key":"7864_CR55","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","volume":"181","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Ukidve A, Kim J, Mitragotri S. Targeting strategies for tissue-specific drug delivery. Cell. 2020;181:151\u201367.","journal-title":"Cell"},{"key":"7864_CR56","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid nanoparticles\u2500from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano. 2021;15:16982\u20137015.","journal-title":"ACS Nano"},{"key":"7864_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114417","volume":"188","author":"T Nakamura","year":"2022","unstructured":"Nakamura T, Sato Y, Yamada Y, Abd Elwakil MM, Kimura S, Younis MA, et al. Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines. Adv Drug Deliv Rev. 2022;188:114417.","journal-title":"Adv Drug Deliv Rev"},{"key":"7864_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.126564","volume":"253","author":"G Zhang","year":"2023","unstructured":"Zhang G, Zhang M, Pei Y, Qian K, Xie J, Huang Q, et al. Enhancing stability of liposomes using high molecular weight chitosan to promote antioxidative stress effects and lipid-lowering activity of encapsulated lutein in vivo and in vitro. Int J Biol Macromol. 2023;253:126564.","journal-title":"Int J Biol Macromol"},{"key":"7864_CR59","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1038\/s41557-024-01584-z","volume":"16","author":"CP Pilkington","year":"2024","unstructured":"Pilkington CP, Gispert I, Chui SY, Seddon JM, Elani Y. Engineering a nanoscale liposome-in-liposome for in situ biochemical synthesis and multi-stage release. Nat Chem. 2024;16:1612\u201320.","journal-title":"Nat Chem"},{"key":"7864_CR60","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abm1262","volume":"15","author":"E Moles","year":"2023","unstructured":"Moles E, Howard CB, Huda P, Karsa M, McCalmont H, Kimpton K, et al. Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia. Sci Transl Med. 2023;15:eabm1262.","journal-title":"Sci Transl Med"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07864-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07864-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07864-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:09:36Z","timestamp":1759777776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07864-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7864"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07864-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the ethics committee of the Affiliated Cancer Hospital of Nanjing Medical University. Samples were sourced from the biobank of Jiangsu Province Cancer Hospital (Jiangsu Province Cancer Research Institute and the Affiliated Cancer Hospital of Nanjing Medical University). All patients had signed informed consent forms for the donation of samples. The biopsy samples received approval from the Ethics Committee of Zhongda Hospital affiliated with Southeast University. All animal experimental methods were performed with the approval of the Ethics-by-Ethics Committee of Southeast University (20190225004).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the patients involved in our study obtained written consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"685"}}